Ulipristal acetate simultaneously provokes antiproliferative and proinflammatory responses in endometrial cancer cells.

Kanda, Ranka; Miyagawa, Yuko; Wada-Hiraike, Osamu; Hiraike, Haruko; Nagasaka, Kazunori; Ryo, Eiji; Fujii, Tomoyuki; Osuga, Yutaka; Ayabe, Takuya.

Afiliação

Kanda R; Department of Obstetrics and Gynecology, Teikyo University School of Medicine, Tokyo, Japan.
Miyagawa Y; Department of Obstetrics and Gynecology, Teikyo University School of Medicine, Tokyo, Japan.
Wada-Hiraike O; Department of Obstetrics and Gynecology, The University of Tokyo, 7-3-1 Hongo Bunkyo-ku, Tokyo 113-8655, Japan.
Hiraike H; Department of Obstetrics and Gynecology, Teikyo University School of Medicine, Tokyo, Japan.
Nagasaka K; Department of Obstetrics and Gynecology, Teikyo University School of Medicine, Tokyo, Japan.
Ryo E; Department of Obstetrics and Gynecology, Teikyo University School of Medicine, Tokyo, Japan.
Fujii T; Department of Obstetrics and Gynecology, The University of Tokyo, 7-3-1 Hongo Bunkyo-ku, Tokyo 113-8655, Japan.
Osuga Y; Department of Obstetrics and Gynecology, The University of Tokyo, 7-3-1 Hongo Bunkyo-ku, Tokyo 113-8655, Japan.
Ayabe T; Department of Obstetrics and Gynecology, Teikyo University School of Medicine, Tokyo, Japan.

Heliyon ; 8(1): e08696, 2022 Jan.

Article em En | MEDLINE | ID: mdl-35036597

Palavras-chave

Apoptosis; Progesterone receptor modulatorassociated endometrial change; Proinflammatory cytokine; Selective progesterone receptor modulator; Ulipristal acetate

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article